|
|
 |
|
Viewing report
|
|
|
|
The Top 30 Transmucosal Drug Delivery Technology Companies Worldwide
Research Facts Ltd, Feb 2011, Pages: 90
Transmucosal routes of drug delivery (i.e., the mucosal linings of the nasal, rectal, vaginal, ocular, and oral cavity) are well established. For example, the oral transmucosal route has been used for many years to provide rapid blood nitrate levels for the treatment of angina pectoris. They offer distinct advantages over other routes of administration including:
- Well suited for both systemic and localised conditions.
- Bypass of first-pass metabolism by the liver.
- Improved drug absorption (the stratum corneum epidermidis, the major barrier to absorption across the skin, is absent from the mucosal linings).
- Rapid onset of action.
- Sustained delivery of products over a pre-determined period of time.
- Noninvasive and convenient administration.
The first large-selling medicine to be adapted to transmucosal delivery was a lozenge formulation of fentanyl citrate known as Actiq. Actiq’s maker Cephalon subsequently produced a generic version of the medicine and in 2007, the two transmucosal fentanyl citrate preparations recorded sales of Euro 297 million. Other developers of transmucosal delivery systems are commercialising technologies to treat such diverse conditions as angina pectoris, breakthrough cancer pain, diabetes, erectile dysfunction, hypogonadism, insomnia, migraine, moderate to severe chronic pain, nausea/vomiting, opioid dependence, osteoporosis, overactive bladder, pre-procedure anxiety and Sjögren's syndrome. It is no surprise to learn then that the transmucosal drug delivery market was estimated to be worth Euro 1.48 billion in 2010.
There are many drug delivery technology companies worldwide. This report profiles the Top 30 transmucosal ones. These are the companies with the most innovative and effective technologies and the largest intellectual property estates.
Profile information for each company in The Top 30 Transmucosal Drug Delivery Technology Companies Worldwide typically includes:
- Company Contact Information - Address, Telephone and Fax Numbers, Email and Website Addresses
- Key Company Decision Makers - From CEO and Main Board, to Key Senior Managers
- Specialised fields such as Company Description, Ownership, Products, Technology, Therapeutic Areas, IP Status, Year Established, Number of Employees and Turnover.
Report Target Market:
1) Drug Delivery Technology Companies
Usage: competitive/financial analysis and strategic partner/alliance identification.
2) Pharmaceutical Companies
This report is perfect for pharmaceutical companies who wish to identify leading, novel and proprietary transmucosal drug delivery technologies.
3) Suppliers
The Top 30 Transmucosal Drug Delivery Technology Companies Worldwide is useful to suppliers of e.g. bioadhesives, to identify new potential customers.
Note: Most people will be aware of some of the major transmucosal drug delivery technology companies such as Aegis Therapeutics, LLC and Cima Labs Inc. but this report looks at all 30 of the top companies - companies like - ULURU Inc. - headquartered in Addison, Texas, United States, the company has developed a novel transmucosal drug delivery device (OraDisc™). The multi-layered device can deliver drugs systemically across the mucosal surface or for the release of drugs into the oral cavity. The device causes minimum discomfort, is easy to apply and capable of providing tailored erosion rates to deliver therapeutics over different time intervals.
Report data field structure is as follows:
Company Name
Mailing Address
Street Address
Telephone
Fax
Email
Website
Parent Company Name
Year Established
Number of Employees
Key Executives
Company Description
Products
Technology
Therapeutic Areas
IP Status
Turnover €m
Location Status
Ownership
Research Facts is a world leader in life sciences publishing. It was established in Dublin, Ireland in 2004. Its partners have over forty years combined experience in the business information industry. Research Facts’ customers include most of the world’s major diagnostics, pharmaceutical, biotechnology and medical device companies e.g. Abbott, Allergan, B. Braun, Bayer, Baxter, Biomet, Boehringer Ingelheim, Covance, Edwards Lifesciences, GE Healthcare, Genzyme, Intuitive Surgical, Ipsen, Medtronic, Millipore, Philips Medical, Qiagen, Siemens Healthcare, Smith & Nephew, Zentiva etc..
Research Facts has customers right across the globe e.g. Austria, Australia, Belgium, Brazil, Canada, Cyprus, Czech Republic, Denmark, France, Germany, Finland, Hungary, India, Ireland, Israel, Italy, Japan, Korea, Kuwait, Luxembourg, Mauritius, Netherlands, Pakistan, Portugal, Russia, Saudi Arabia, Slovenia, South Africa, Spain, Sweden, Switzerland, United Kingdom, and the United States.
Research Facts’ reports help you make informed decisions about the markets and organisations that affect your business.
- Learn more about your target markets and target companies
- Top level research on all the major players in a market
- See which organisations dominate your major markets
- Get detailed information on particular organisations
Formats:
Hardcopy: Bound report, A4 format, 90 pages
Electronic: pdf Version, A4 format, 90 pages
Author: The scientific advisor on this report was Katie Ryan. Katie has degrees in physiology and medicine from Trinity College Dublin and is a full-time researcher there in the School of Medicine.
Keywords:
Buccal, Drug Delivery, Nasal, Ocular, Rectal, Subgingival, Sublingual, Transmucosal, Vaginal.
|
|
|
|
